Characteristics of a CCL21-gene modified dendritic cell vaccine utilized for a clinical trial in non-small cell lung cancer
Ontology highlight
ABSTRACT: Characteristics of a CCL21-gene modified dendritic cell vaccine utilized for a clinical trial in non-small cell lung cancer
PROVIDER: PRJNA1135255 | ENA |
REPOSITORIES: ENA
ACCESS DATA